Tevogen Bio secures an $8 million grant upon positive progress review, enhancing its AI-driven predictive modeling for immunotherapy. Tevogen Bio has announced that it will receive the remaining $8 ...
A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s machine learning ...
Online dating can be a minefield, and it’s hard to stand out. On Tinder, it’s usually the profile pictures that grab our attention, but the bios that make our decision on whether we give somebody a ...
PARIS, March 09, 2026 (GLOBE NEWSWIRE) -- kyron.bio, a biotechnology company pioneering precision glycoengineering for antibody therapeutic development, today announced a strategic partnership with ...
The drug is under Priority Review by the U.S. Food and Drug Administration (FDA) and has a Prescription Drug User Fee Act (PDUFA) date of June 23, 2025 NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc.
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird's fall from the one of the buzziest biotech ...
Q32 Bio on Monday sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics Inc. (NASDAQ: AKBA). ADX-097, the lead product candidate from Q32 Bio’s tissue-targeted complement inhibitor ...
HOUSTON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Systemic Bio™, a 3D Systems (NYSE:DDD) company, is excited to announce the acceptance of two abstracts for presentation at the prestigious Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results